About us

Lynx Biosciences, Inc. (LynxBio®) is a clinical-stage biotechnology company combining physiologically relevant suspension cell co-culture assays, automated microfluidics, and deep learning analytics with the goal of rapidly advancing drug candidates in oncology and bringing personalized cancer treatments to patients.

As a (re)mission-driven company, we leverage this clinically-proven platform to address unmet medical needs in oncology, with an initial focus on hematological malignancies. To date, we have entered into collaborations with 10+ NCI-designated cancer centers as well as Top 20 pharmaceutical companies to advance promising drug candidates and identify predictive biomarkers in clinical studies.

Lorem ipsum dolor
sit amet elitase.

 

About us

As a (re)mission-driven company, we leverage this clinically-proven platform to address unmet medical needs in oncology, with an initial focus on hematological malignancies. To date, we have entered into collaborations with 10+ NCI-designated cancer centers as well as Top 20 pharmaceutical companies to advance promising drug candidates and identify predictive biomarkers in clinical studies.

3210 Merryfield Row

San Diego, CA 92121-1126

Stay Connected

  • White LinkedIn Icon
  • White Twitter Icon
  • Email icon-02

All content copyright © 2020 Lynx Biosciences™, Inc. All rights reserved. LynxBio   is a registered trademark of Lynx Biosciences™, Inc.

®